The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Lyme Disease Testing Market Research Report 2025
Synopsis
Lyme disease is caused by the bacterium Borrelia burgdorferi and rarely, Borrelia mayonii. It is transmitted to humans through the bite of infected blacklegged ticks. Typical symptoms include fever, headache, fatigue, and a characteristic skin rash called erythema migrans. Lyme disease is usually diagnosed by serology. RIPL uses a modified 2-tier testing approach. The initial screening test is a combined IgG and IgM ELISA that detects antibodies against 2 Borrelia burgdorferi antigens – VlsE1 and pepC10.
The global Lyme Disease Testing market was valued at US$ 200.5 million in 2023 and is anticipated to reach US$ 315.9 million by 2030, witnessing a CAGR of 6.6% during the forecast period 2024-2030.
Global key players of Lyme Disease Testing include Quidel Corporation, Roche Holding AG and Fujirebio(H.U. Group Holdings), etc. Global top three manufacturers hold a share about 25%. North America is the largest market of Lyme Disease Testing, with a share over 60%, followed by Asia-Pacific and Europe.
This report aims to provide a comprehensive presentation of the global market for Lyme Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lyme Disease Testing.
Report Scope
The Lyme Disease Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lyme Disease Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lyme Disease Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Quidel Corporation
Roche Holding AG
Fujirebio(H.U. Group Holdings)
ZEUS Scientific
IGeneX
Thermo Fisher Scientific
Everlywell
Oxford Immunotec Global PLC(PerkinElmer)
BioMerieux
Bio-Rad Laboratories
T2 Biosystems
Segment by Type
ELISA
Western Blotting
PCR
Others
Segment by Application
Hospital and Testing Agency
Personal
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lyme Disease Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Lyme disease is caused by the bacterium Borrelia burgdorferi and rarely, Borrelia mayonii. It is transmitted to humans through the bite of infected blacklegged ticks. Typical symptoms include fever, headache, fatigue, and a characteristic skin rash called erythema migrans. Lyme disease is usually diagnosed by serology. RIPL uses a modified 2-tier testing approach. The initial screening test is a combined IgG and IgM ELISA that detects antibodies against 2 Borrelia burgdorferi antigens – VlsE1 and pepC10.
The global Lyme Disease Testing market was valued at US$ 200.5 million in 2023 and is anticipated to reach US$ 315.9 million by 2030, witnessing a CAGR of 6.6% during the forecast period 2024-2030.
Global key players of Lyme Disease Testing include Quidel Corporation, Roche Holding AG and Fujirebio(H.U. Group Holdings), etc. Global top three manufacturers hold a share about 25%. North America is the largest market of Lyme Disease Testing, with a share over 60%, followed by Asia-Pacific and Europe.
This report aims to provide a comprehensive presentation of the global market for Lyme Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lyme Disease Testing.
Report Scope
The Lyme Disease Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lyme Disease Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lyme Disease Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Quidel Corporation
Roche Holding AG
Fujirebio(H.U. Group Holdings)
ZEUS Scientific
IGeneX
Thermo Fisher Scientific
Everlywell
Oxford Immunotec Global PLC(PerkinElmer)
BioMerieux
Bio-Rad Laboratories
T2 Biosystems
Segment by Type
ELISA
Western Blotting
PCR
Others
Segment by Application
Hospital and Testing Agency
Personal
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lyme Disease Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lyme Disease Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 ELISA
1.2.3 Western Blotting
1.2.4 PCR
1.2.5 Others
1.3 Market by Application
1.3.1 Global Lyme Disease Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital and Testing Agency
1.3.3 Personal
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lyme Disease Testing Market Perspective (2019-2030)
2.2 Lyme Disease Testing Growth Trends by Region
2.2.1 Global Lyme Disease Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Lyme Disease Testing Historic Market Size by Region (2019-2024)
2.2.3 Lyme Disease Testing Forecasted Market Size by Region (2025-2030)
2.3 Lyme Disease Testing Market Dynamics
2.3.1 Lyme Disease Testing Industry Trends
2.3.2 Lyme Disease Testing Market Drivers
2.3.3 Lyme Disease Testing Market Challenges
2.3.4 Lyme Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lyme Disease Testing Players by Revenue
3.1.1 Global Top Lyme Disease Testing Players by Revenue (2019-2024)
3.1.2 Global Lyme Disease Testing Revenue Market Share by Players (2019-2024)
3.2 Global Lyme Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lyme Disease Testing Revenue
3.4 Global Lyme Disease Testing Market Concentration Ratio
3.4.1 Global Lyme Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lyme Disease Testing Revenue in 2023
3.5 Lyme Disease Testing Key Players Head office and Area Served
3.6 Key Players Lyme Disease Testing Product Solution and Service
3.7 Date of Enter into Lyme Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lyme Disease Testing Breakdown Data by Type
4.1 Global Lyme Disease Testing Historic Market Size by Type (2019-2024)
4.2 Global Lyme Disease Testing Forecasted Market Size by Type (2025-2030)
5 Lyme Disease Testing Breakdown Data by Application
5.1 Global Lyme Disease Testing Historic Market Size by Application (2019-2024)
5.2 Global Lyme Disease Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Lyme Disease Testing Market Size (2019-2030)
6.2 North America Lyme Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Lyme Disease Testing Market Size by Country (2019-2024)
6.4 North America Lyme Disease Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lyme Disease Testing Market Size (2019-2030)
7.2 Europe Lyme Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Lyme Disease Testing Market Size by Country (2019-2024)
7.4 Europe Lyme Disease Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lyme Disease Testing Market Size (2019-2030)
8.2 Asia-Pacific Lyme Disease Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Lyme Disease Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Lyme Disease Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lyme Disease Testing Market Size (2019-2030)
9.2 Latin America Lyme Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Lyme Disease Testing Market Size by Country (2019-2024)
9.4 Latin America Lyme Disease Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lyme Disease Testing Market Size (2019-2030)
10.2 Middle East & Africa Lyme Disease Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Lyme Disease Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Lyme Disease Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Quidel Corporation
11.1.1 Quidel Corporation Company Detail
11.1.2 Quidel Corporation Business Overview
11.1.3 Quidel Corporation Lyme Disease Testing Introduction
11.1.4 Quidel Corporation Revenue in Lyme Disease Testing Business (2019-2024)
11.1.5 Quidel Corporation Recent Development
11.2 Roche Holding AG
11.2.1 Roche Holding AG Company Detail
11.2.2 Roche Holding AG Business Overview
11.2.3 Roche Holding AG Lyme Disease Testing Introduction
11.2.4 Roche Holding AG Revenue in Lyme Disease Testing Business (2019-2024)
11.2.5 Roche Holding AG Recent Development
11.3 Fujirebio(H.U. Group Holdings)
11.3.1 Fujirebio(H.U. Group Holdings) Company Detail
11.3.2 Fujirebio(H.U. Group Holdings) Business Overview
11.3.3 Fujirebio(H.U. Group Holdings) Lyme Disease Testing Introduction
11.3.4 Fujirebio(H.U. Group Holdings) Revenue in Lyme Disease Testing Business (2019-2024)
11.3.5 Fujirebio(H.U. Group Holdings) Recent Development
11.4 ZEUS Scientific
11.4.1 ZEUS Scientific Company Detail
11.4.2 ZEUS Scientific Business Overview
11.4.3 ZEUS Scientific Lyme Disease Testing Introduction
11.4.4 ZEUS Scientific Revenue in Lyme Disease Testing Business (2019-2024)
11.4.5 ZEUS Scientific Recent Development
11.5 IGeneX
11.5.1 IGeneX Company Detail
11.5.2 IGeneX Business Overview
11.5.3 IGeneX Lyme Disease Testing Introduction
11.5.4 IGeneX Revenue in Lyme Disease Testing Business (2019-2024)
11.5.5 IGeneX Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Detail
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Lyme Disease Testing Introduction
11.6.4 Thermo Fisher Scientific Revenue in Lyme Disease Testing Business (2019-2024)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Everlywell
11.7.1 Everlywell Company Detail
11.7.2 Everlywell Business Overview
11.7.3 Everlywell Lyme Disease Testing Introduction
11.7.4 Everlywell Revenue in Lyme Disease Testing Business (2019-2024)
11.7.5 Everlywell Recent Development
11.8 Oxford Immunotec Global PLC(PerkinElmer)
11.8.1 Oxford Immunotec Global PLC(PerkinElmer) Company Detail
11.8.2 Oxford Immunotec Global PLC(PerkinElmer) Business Overview
11.8.3 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Introduction
11.8.4 Oxford Immunotec Global PLC(PerkinElmer) Revenue in Lyme Disease Testing Business (2019-2024)
11.8.5 Oxford Immunotec Global PLC(PerkinElmer) Recent Development
11.9 BioMerieux
11.9.1 BioMerieux Company Detail
11.9.2 BioMerieux Business Overview
11.9.3 BioMerieux Lyme Disease Testing Introduction
11.9.4 BioMerieux Revenue in Lyme Disease Testing Business (2019-2024)
11.9.5 BioMerieux Recent Development
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Detail
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories Lyme Disease Testing Introduction
11.10.4 Bio-Rad Laboratories Revenue in Lyme Disease Testing Business (2019-2024)
11.10.5 Bio-Rad Laboratories Recent Development
11.11 T2 Biosystems
11.11.1 T2 Biosystems Company Detail
11.11.2 T2 Biosystems Business Overview
11.11.3 T2 Biosystems Lyme Disease Testing Introduction
11.11.4 T2 Biosystems Revenue in Lyme Disease Testing Business (2019-2024)
11.11.5 T2 Biosystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
